Genes2Me Pvt. Ltd., one of the leading IVD solution manufacturer of India, is elated to announce the launch of its CoviEasy Self-Test Rapid Antigen test kit for COVID-19 that is easy to use and give faster results in 10 minutes. Backed by AI driven Mobile App, this IVD product delivers high level of sensitivity and…
In hospitalized patients with COVID-19 Pneumonia, the rates of clinical events among those treated with Reparixin (n=36) were statistically significantly lower than standard of care (n=19). The study is the first evaluation of the efficacy and safety of Reparixin an IL-8 inhibitor in patients with severe COVID-19 pneumonia. Results from the Phase 2 trial were…
| Powered by WordPress | Theme by TheBootstrapThemes